One position of Postdoctoral Fellow or Research Associate to study novel molecular mechanisms of cancer progression is available in Dr. Wenliang Li’s lab at the Institute of Molecular Medicine (IMM) of the University of Texas Health Science Center at Houston (UTHealth).
Metastasis is responsible for over 90% of cancer death but its mechanisms are still poorly understood. Research in Dr. Li’s lab is to study novel regulators of cancer metastasis, epithelial-mesenchymal transition (EMT), and drug resistance through a unique combination of RNAi/cDNA screens, cancer genomics, molecular cell biology, mouse models and patient specimens. The goals of the research are to gain new knowledge of cancer progression, identify novel cancer drug targets and develop better therapeutics.
Qualified candidates should have a doctoral degree, strong background and good first-author publications in cancer biology, molecular cell biology, or signal transduction. Prior experience in mouse models is desirable but not required. The postdoc fellow is expected to have strong work ethic, critical thinking abilities, excellent organization and communication skills.
UTHealth is located in the heart of the Texas Medical Center, the world's largest medical center, in the 4th largest city of US with a reasonable living cost. The minimal annual salary for postdoc fellow is $47,500. UTHealth is an EEO/AA employer. UTHealth does not discriminate on the basis of race, color, religion, gender, sexual orientation, national origin, genetics, disability, age, or any other basis prohibited by law.EOE/M/D/F/V….
中国-博士人才网发布
